We are excited to announce that HCmed will join the Drug Delivery to the Lungs (DDL) 2022 Conference.

Our team looks forward to meeting pharmaceutical companies interested in the development of drug-nebulizer combination products, introducing our CDMO services and mesh nebulizer platforms to deliver inhaled formulations.

Booth No.: 228.

During the conference, the results of our latest research on emission of fugitive aerosols will also be presented. Don't miss the chance to check out our poster abstract.

Poster No.: 67
Title: Assessment of Fugitive Aerosol Emission During Actuation of a Breath-actuated Mesh Nebuliser
 

---